Ionis Pharmaceuticals (IONS) Leases: 2010-2025
Historic Leases for Ionis Pharmaceuticals (IONS) over the last 3 years, with Sep 2025 value amounting to $242.0 million.
- Ionis Pharmaceuticals' Leases rose 47.18% to $242.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $242.0 million, marking a year-over-year increase of 47.18%. This contributed to the annual value of $161.9 million for FY2024, which is 5.84% down from last year.
- As of Q3 2025, Ionis Pharmaceuticals' Leases stood at $242.0 million, which was up 47.62% from $163.9 million recorded in Q2 2025.
- In the past 5 years, Ionis Pharmaceuticals' Leases registered a high of $242.0 million during Q3 2025, and its lowest value of $18.0 million during Q4 2021.
- In the last 3 years, Ionis Pharmaceuticals' Leases had a median value of $169.4 million in 2024 and averaged $175.4 million.
- Per our database at Business Quant, Ionis Pharmaceuticals' Leases skyrocketed by 910.04% in 2022 and then declined by 6.00% in 2025.
- Ionis Pharmaceuticals' Leases (Quarterly) stood at $18.0 million in 2021, then soared by 910.04% to $181.5 million in 2022, then declined by 5.31% to $171.9 million in 2023, then decreased by 5.84% to $161.9 million in 2024, then surged by 47.18% to $242.0 million in 2025.
- Its Leases stands at $242.0 million for Q3 2025, versus $163.9 million for Q2 2025 and $159.3 million for Q1 2025.